CD274 and neoplasm: The limitation of immunotherapy in solid tumors is the activation of multiple immunosuppressive components in the tumor microenvironment (28). A low level expression of the PD-L1 in tumors alone cannot explain the lack of responsiveness in the majority of patients, nor can a low number of tumor mutational burden (TMB).